3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
53
Lung Neoplasms
24
Breast Neoplasms
22
Head and Neck Neoplasms
14
Adenocarcinoma of Lung
11
Neoplasms
7
Esophageal Neoplasms
7
Brain Neoplasms
7
Prostatic Neoplasms
6
Adenocarcinoma, Bronchiolo-Alveolar
6
Neoplasm Metastasis
5
Glioblastoma
5
Adenocarcinoma Of Esophagus
5
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Ovarian Neoplasms
4
Gliosarcoma
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Adenocarcinoma
4
Urinary Bladder Neoplasms
3
Kidney Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Skin Neoplasms
2
Neoplasms, Squamous Cell
2
Mesothelioma, Malignant
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Diseases
2
Interventions
Gefitinib
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Advanced Stage Non Small Cell Lung Cancer
×
Gefitinib
×
Clear all
NCT01955421
2015-07-03
NSCLC EGFR TKI
Sun Yat-sen University
Phase 2
Unknown
224 enrolled